Category
Research
Clinical trials, observational studies, and meta-analyses examining ibogaine and its metabolites in the treatment of substance use disorders.
Why noribogaine's long half-life complicates dosing protocols
Ibogaine's primary metabolite, noribogaine, persists in plasma for days after a single dose, raising questions about cumulative cardiac exposure that current monitoring protocols may not fully capture.
SO
Dr. Samuel Okafor11 min readNeuroplasticity claims about ibogaine: what preclinical models actually show
Animal studies suggest ibogaine and noribogaine upregulate GDNF and BDNF expression. Translating those findings into claims about clinical efficacy requires distinctions that popular coverage often blurs.
JW
Dr. Jonas Weil10 min read